These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9666755)

  • 1. C-reactive protein: a predictor of peripheral artery disease.
    Harv Heart Lett; 1998 Jul; 8(11):6-7. PubMed ID: 9666755
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 3. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for progression of peripheral arterial disease in large and small vessels.
    Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A
    Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
    Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
    Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
    de Berrazueta JR; Sampedro I; Garcia-Unzueta MT; Llorca J; Bustamante M; Amado JA
    Am Heart J; 2003 Oct; 146(4):E14. PubMed ID: 14564337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel risk factors for peripheral arterial disease in young women.
    Bloemenkamp DG; van den Bosch MA; Mali WP; Tanis BC; Rosendaal FR; Kemmeren JM; Algra A; Visseren FL; van der Graaf Y
    Am J Med; 2002 Oct; 113(6):462-7. PubMed ID: 12427494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the risk factors for atherosclerosis on levels of soluble adhesion molecules and endothelial markers in peripheral vascular disease.
    Blann AD; Lip GY; McCollum CN
    Thromb Haemost; 2002 Aug; 88(2):366-7. PubMed ID: 12195717
    [No Abstract]   [Full Text] [Related]  

  • 10. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arteriopathy of the lower limbs].
    Rodríguez Padial L; Dobbs Domínguez M
    Med Clin (Barc); 1997 Jun; 109(2):53-4. PubMed ID: 9280802
    [No Abstract]   [Full Text] [Related]  

  • 13. C-reactive protein (CRP) as a marker in peripheral vascular disease.
    Abdellaoui A; Al-Khaffaf H
    Eur J Vasc Endovasc Surg; 2007 Jul; 34(1):18-22. PubMed ID: 17296319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of cigarette smoking to peripheral arterial disease.
    Lu JT; Creager MA
    Rev Cardiovasc Med; 2004; 5(4):189-93. PubMed ID: 15580157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid lowering doesn't affect the development of atherosclerosis in peripheral artery disease].
    Ravnskov U
    Lakartidningen; 2001 Oct; 98(44):4897-8. PubMed ID: 11729806
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
    Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
    Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A; Limmert T; Hoffmann U
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 19. C-reactive protein, atherosclerosis and cardiovascular disease. An update.
    Camici M
    Minerva Cardioangiol; 2002 Aug; 50(4):327-31. PubMed ID: 12147963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vascular complications of acromegaly.
    Bondanelli M; Zatelli MC; Ambrosio MR; degli Uberti EC
    J Endocrinol Invest; 2003; 26(8 Suppl):28-31. PubMed ID: 15233208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.